SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Bio-Path Holdings, Inc. to Expand Development of Liposomal Grb-2 Into Two Additional Indications: Triple Negative and Inflammatory Breast Cancers